The US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted on 28 February on use of the first approved chikungunya virus vaccine for several groups of people.
Valneva SE’s Ixchiq received accelerated approval on 9 November for prevention of disease caused by chikungunya virus in individuals...







